Growth Metrics

DBV Technologies (DBVT) Change in Accured Expenses (2017 - 2026)

DBV Technologies (DBVT) reported Change in Accured Expenses of -$4.7 million for Q1 2026, down 51.61% year-over-year from -$9.7 million in Q1 2025, and down 165.46% on a QoQ basis from $7.2 million in Q4 2025.

DBV Technologies (DBVT) has 10 years of Change in Accured Expenses data on file, last reported at -$4.7 million in Q1 2026.

  • Quarterly Change in Accured Expenses fell 51.61% year-over-year to -$4.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.9 million (up 377.3% YoY) and the FY2025 annual result came in at $6.5 million, up 1681.69% from the prior year.
  • Change in Accured Expenses slipped to -$4.7 million in Q1 2026 per DBVT's latest filing, from $7.2 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $7.2 million in Q4 2025 and bottomed at -$4.7 million in Q1 2026.
  • The 5-year median for Change in Accured Expenses is $366000.0 (2023), against an average of -$176176.5.
  • The widest annual swing landed in 2023, when Change in Accured Expenses slumped 178.35%; it then surged 1463.16% in 2024.
  • Tracing DBVT's Change in Accured Expenses over 5 years: stood at $3.6 million in 2022, then tumbled by 178.35% to -$2.8 million in 2023, then soared by 157.09% to $1.6 million in 2024, then surged by 351.29% to $7.2 million in 2025, then plunged by 165.46% to -$4.7 million in 2026.
  • Per Business Quant, the three latest DBVT Change in Accured Expenses figures stand at -$4.7 million (Q1 2026), $7.2 million (Q4 2025), and $868000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 931,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 70.50 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 107.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -176.03 Mn
10 DBV Technologies 8.00 Bn 7.77 Bn -3.90 Mn -4.70 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -4.70 Mn
Mar 31, 2026 -4.70 Mn
Dec 31, 2025 7.18 Mn
Dec 31, 2025 7.18 Mn
Sep 30, 2025 868,000.00
Sep 30, 2025 868,000.00
Jun 30, 2025 1.57 Mn
Jun 30, 2025 1.57 Mn
Mar 31, 2025 -3.10 Mn
Mar 31, 2025 -3.10 Mn
Dec 31, 2024 1.59 Mn
Dec 31, 2024 1.59 Mn
Sep 30, 2024 1.35 Mn
Sep 30, 2024 1.35 Mn
Jun 30, 2024 1.19 Mn
Jun 30, 2024 1.19 Mn
Mar 31, 2024 -3.77 Mn
Mar 31, 2024 -3.77 Mn
Dec 31, 2023 -2.79 Mn
Dec 31, 2023 -2.79 Mn
Sep 30, 2023 366,000.00
Sep 30, 2023 366,000.00
Jun 30, 2023 76,000.00
Jun 30, 2023 76,000.00
Mar 31, 2023 -2.99 Mn
Mar 31, 2023 -2.99 Mn
Dec 31, 2022 3.56 Mn
Dec 31, 2022 3.56 Mn
Sep 30, 2022 -365,000.00
Sep 30, 2022 -365,000.00
Jun 30, 2022 1.08 Mn
Jun 30, 2022 1.08 Mn
Mar 31, 2022 -4.12 Mn
Mar 31, 2022 -4.12 Mn
Dec 31, 2021 -2.10 Mn
Dec 31, 2021 -2.10 Mn
Sep 30, 2021 1.11 Mn
Sep 30, 2021 1.11 Mn
Jun 30, 2021 1.37 Mn
Jun 30, 2021 1.37 Mn
Mar 31, 2021 -7.98 Mn
Mar 31, 2021 -7.98 Mn
Dec 31, 2020 8.02 Mn
Dec 31, 2020 8.02 Mn
Sep 30, 2020 -6.19 Mn
Sep 30, 2020 -6.19 Mn
Jun 30, 2020 3.20 Mn
Jun 30, 2020 3.20 Mn
Mar 31, 2020 -8.38 Mn
Mar 31, 2020 -8.38 Mn
Sep 30, 2019 8.71 Mn
Sep 30, 2019 8.71 Mn
Dec 31, 2018 -7.41 Mn
Dec 31, 2018 -7.41 Mn
Sep 30, 2018 -2.21 Mn
Sep 30, 2018 -2.21 Mn
Jun 30, 2018 -5.20 Mn
Jun 30, 2018 -5.20 Mn
Dec 31, 2017 -666,426.81
Dec 31, 2017 -666,426.81